Chinese Herbal Formula (CHF03) Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) Through Inhibiting Lipogenesis and Anti-Oxidation Mechanisms

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2019.01190
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

Diagnosis of Non-Alcoholic Fatty Liver Disease (NAFLD)

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

miR-122 Promotes Hepatic Lipogenesis via Inhibiting the LKB1/AMPK Pathway by Targeting Sirt1 in Non-Alcoholic Fatty Liver Disease

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2019English

The Role of Dietary Sugars and De Novo Lipogenesis in Non-Alcoholic Fatty Liver Disease

Nutrients
NutritionFood ScienceDietetics
2014English

Non-Alcoholic Fatty Liver Disease and Disease Mongering

American Journal of Medicine
Medicine
2019English

The Role of Hepatic Fat Accumulation in Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD)

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2010English

Global Perspectives on Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Hepatology
MedicineHepatology
2019English

Treatment of Non-Alcoholic Fatty Liver Disease

Postgraduate Medical Journal
Medicine
2006English

Insulin Resistance in Non-Diabetic Patients With Non-Alcoholic Fatty Liver Disease: Sites and Mechanisms

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2005English

Serum Amylase Levels Are Decreased in Chinese Non-Alcoholic Fatty Liver Disease Patients

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy